Today: 2 February 2026
Subscribe
Browse Category

NASDAQ:IESC News 17 December 2025

IES Holdings (IESC) Stock Drops on Dec. 17, 2025: What’s Driving the Move, Latest Earnings, Insider Sales, and Wall Street Forecasts

IES Holdings (IESC) Stock Drops on Dec. 17, 2025: What’s Driving the Move, Latest Earnings, Insider Sales, and Wall Street Forecasts

IES Holdings, Inc. (NASDAQ: IESC) saw a sharp pullback in Wednesday trading on December 17, 2025, after a strong multi-year run that has increasingly tied the company’s narrative to data center demand, capacity expansion, and active capital allocation. As of the latest available trade on Dec. 17, IESC was trading around $405, down roughly 9% from the prior close (after…
17 December 2025
·····

Stock Market Today

  • Cantor Fitzgerald Raises Price Target for Regeneron Pharmaceuticals (NASDAQ:REGN)
    February 2, 2026, 11:58 AM EST. Cantor Fitzgerald increased its price target on Regeneron Pharmaceuticals (NASDAQ:REGN) from $740 to $800, maintaining an "overweight" rating, signaling a potential 5% upside. Other brokerages also raised forecasts, with BMO Capital Markets at $850, Guggenheim at $865, and Evercore ISI at $875. Regeneron's shares rose 2.7% to $761.32 amid increased trading volume. The biotech giant posted strong Q4 results with EPS of $11.44 beating estimates, and revenues up 2.5% year-over-year to $3.88 billion. The company holds a solid balance sheet with low debt and robust margins. Market consensus rates the stock as a "Moderate Buy" with an average price target near $790, reflecting optimism about Regeneron's growth prospects.
Go toTop